Multi-virus-specific T cell therapy(Icell Biotechnology)

多病毒特异性T细胞疗法（上海赛傲生物）

Report date: 2024/12/20 15:48:46

Base Information

Drug NameMulti-virus-specific T cell therapy(Icell Biotechnology)
Drug Alias NameVST cell therapy(Icell Biotechnology)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsEpstein-Barr Virus InfectionsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShanghai Icell Biotechnology Co., Ltd, Shanghai, China
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Icell Biotechnology Co., Ltd, Shanghai, ChinaPeking University People'S Hospital
Inactive CompaniesN/A
Active IndicationsEpstein-Barr Virus InfectionsCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A